Cardiovascular autonomic neuropathy in type 2 diabetic patients.

Autor: Breder ISS; Endocrinologist - Doctorate Student at the Laboratory of Vascular Biology and Atherosclerosis. -Faculty of medical Sciences (FCM) - State University of Campinas (Unicamp) - Campinas (SP) - Brasil., Sposito AC; Full Professor - Department of Cardiology - Laboratory of Vascular Biology and Atherosclerosis - FCM - Unicamp - São Paulo (SP) - Brasil.
Jazyk: angličtina
Zdroj: Revista da Associacao Medica Brasileira (1992) [Rev Assoc Med Bras (1992)] 2019 Jan; Vol. 65 (1), pp. 56-60.
DOI: 10.1590/1806-9282.65.1.56
Abstrakt: Diabetes is one of the most common chronic pathologies around the world, involving treatment with general clinicians, endocrinologists, cardiologists, ophthalmologists, nephrologists and a multidisciplinary team. Patients with type 2 Diabetes Mellitus (T2DM) can be affected by cardiac autonomic neuropathy, leading to increased mortality and morbidity. In this review, we will present current concepts, clinical features, diagnosis, prognosis, and possible treatment. New drugs recently developed to reduce glycemic level presented a pleiotropic effect of reducing sudden death, suggesting a potential use in patients at risk.
Databáze: MEDLINE